Atrial fibrillation DCE on oral anticoagulation treatment

Ingress health team members present at DGGOE (March 2015)  the results from a discrete choice experiment (DCE) comparing oral anticoagulation in patients with atrial fibrillation. Since the introduction of the new oral anticoagulants (NOACs), a treatment alternative is available for vitamin K antagonists (VKA) for stroke prevention in atrial fibrillation (AF) patients. The aim of

Lees meer